As an initial application, we developed a high‐multiplex EGFR assay for profiling major EGFR gene mutations in NSCLC, successfully distinguishing up to seven EGFR mutation variants spanning 35 subtypes with four probes and two melting temperatures (Figure 5b; Figure S18a–c, Supporting Information). Here, EGFR is linked to non-small cell lung carcinoma.